Generics 2

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Fluticasone manufacturers

2 products found

Filters

Filters

Filters , active

Country of origin : Spain

Clear all

2 products found

fluticasone

Cream 0.05%- 30g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #644
A pharmaceutical company based in Europe with 30+ years of experience in manufacturing and distribution. The company has several patented technologies and works in pharmaceutical, nutraceutical, and dermatological areas in over 80 countries worldwide (Europe, Central America and Eastern Asia).

Manufacturer usually replies in 6 days

Want to see all 2 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

What is the Fluticasone drug?

Fluticasone is a combination of two manufactured steroids (fluticasone furoate and fluticasone propionate) used to treat symptoms of rhinitis such as sneezing and a runny, stuffy, or itchy nose and itchy, watery eyes. Those two esters can also be used as topical anti-inflammatories and inhaled corticosteroids. Fluticasone works by blocking the release of certain natural substances that cause allergy symptoms. Fluticasone propionate was first approved in 1990, and Fluticasone furoate was passed in 2007.

Fluticasone manufacturers and wholesalers:

Fluticasone is a globally found drug. Fluticasone has many brand names, such as Flonase, Veramyst, Xhance, Childrens Flonase, Flonase Sensimist, Good Sense Nasoflow. Fluticasone manufacturers are Akorn, Roxane Laboratories Inc, and more. Fluticasone suppliers market it in the form of inhalers, 50 mcg/inhalation, 27.5 mcg/inhalation, 93 mcg/inhalation nasal sprays, and topical treatments for various inflammatory indications.

Fluticasone for sales:

In the US, a 50 mcg/inhalation Fluticasone nasal spray costs about $1.8 per gram. In 2017, Fluticasone was the 15th most prescribed medication in the United States.
On Pipelinepharma pharmaceutical market place, Fluticasone is most available from the EU, the US, Turkey, and Taiwan. The online platform helps the distributors to find qualified Fluticasone manufacturers globally, ensuring you they are not fraudulent websites. Using the integrated search engine of the marketplace, you can find a list of many pharmaceutical products for sale, including Fluticasone. Each Fluticasone manufacturer or supplier product description encompasses lots of information about the medication such as form, dose, manufacturing site approvals, and regulatory status. Then using the simple one-click contact form, you can enquire about the supply price if none are listed and place an order or send inquiries to companies no matter where they are in the world. Not only is this marketplace good news for distributors and other buyers, but wholesale sellers and manufacturers benefit as well. They can register and list an unlimited number of pharmaceutical products free of charge.

How to use Fluticasone drugs?

To treat rhinitis, an adult should take two sprays of Fluticasone Furoate in each nostril once a day (it represents 27.5 mcg/spray). Another treatment is one to two sprays of Fluticasone propionate in each nostril once a day (it represents 50 mcg/spray). Taking Fluticasone can cause some side effects, such as headache, dryness, stinging, burning or irritation in the nose, nausea, vomiting, diarrhea, bloody mucus in the nose, dizziness.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation